Eptifibatide Injection
Product Images NDC 70436-162

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 70436-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C1c87763 5f99 4d77 E053 2995a90a6ec9

Packaging label for Eptifibatide Injection, 20 mg/10 mL (2 mg/mL), an intravenous injection. The label indicates the product is for Rx use only, supplied as a single-dose 10 mL vial. It is manufactured by Hainan Poly Pharm. Co., Ltd. and distributed by Slate Run Pharmaceuticals, LLC. The label includes storage instructions and a barcode.*

FDA Label Image

C1c87763 5f9c 4d77 E053 2995a90a6ec9

Packaging label for Eptifibatide Injection 0.75 mg/mL (75 mg/100 mL) single-dose vial. The drug is for intravenous use and weight-adjusted bolus dosing. The label states it is distributed by Slate Run Pharmaceuticals, LLC, and manufactured by Hainan Poly Pharm. Co., Ltd. Storage instructions and a barcode are also visible.*

FDA Label Image

Carton 20mgper10ml V2.2.jpg.jpg.jpg

Packaging label for Eptifibatide Injection 20 mg/10 mL (2 mg/mL) single-dose vial. The label states intravenous use only, weight-adjusted bolus dosing, and includes storage information. Manufactured by Hainan Poly Pharm. Co., Ltd. and distributed by Slate Run Pharmaceuticals, LLC. The label features barcode and trademark PREMIERProRx.*

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram of the active ingredient eptifibatide, showing its molecular components and bonds.*

FDA Label Image

Figure 1 (Image 02)

A line chart comparing the percent of patients with events over 30 days between Eptifibatide treatment and Placebo. The x-axis represents time in days (0 to 30), and the y-axis shows the percent of patients with events (0% to 16%). The solid line represents Eptifibatide, and the dashed line represents Placebo, showing Eptifibatide with a consistently lower percentage of patients with events over time.*

FDA Label Image

75 mg Carton Label (Image 03)

Eptifibatide Injection 0.75 mg/mL (75 mg/100 mL) vial packaging label shows a 100 mL single-dose vial for intravenous use, distributed by Slate Run Pharmaceuticals, LLC. The label includes storage instructions and contents details, with prominent marking of the strength and dosage form. Manufactured by Hainan Poly Pharm. Co., Ltd., China.*

FDA Label Image

Premierprorx Logo (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.